Galmed Pharmaceuticals (NASDAQ:GLMD) Stock Rating Upgraded by Wall Street Zen
Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) was upgraded by investment analysts at Wall Street Zen to a “sell” rating in a research report issued to clients and investors on Saturday. Separately, Maxim Group reissued a “hold” rating on shares of Galmed Pharmaceuticals in a research report on Friday, April 4th. Get Our Latest Stock […]
Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) was upgraded by investment analysts at Wall Street Zen to a “sell” rating in a research report issued to clients and investors on Saturday. Separately, Maxim Group reissued a “hold” rating on shares of Galmed Pharmaceuticals in a research report on Friday, April 4th. Get Our Latest Stock […]
